Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis
Chemotherapeutic intervention remains the primary strategy in treating and controlling tuberculosis (TB). However, a complex interplay between therapeutic and patient-related factors leads to poor treatment adherence. This in turn continues to give rise to unacceptably high rates of disease relapse...
Main Authors: | Sam Afkhami, Anne Drumond Villela, Michael R. D’Agostino, Mangalakumari Jeyanathan, Amy Gillgrass, Zhou Xing |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.557809/full |
Similar Items
-
Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments
by: Rocky Lai, et al.
Published: (2015-06-01) -
Mucosal-Pull Induction of Lung-Resident Memory CD8 T Cells in Parenteral TB Vaccine-Primed Hosts Requires Cognate Antigens and CD4 T Cells
by: Siamak Haddadi, et al.
Published: (2019-09-01) -
Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model.
by: Daniela Damjanovic, et al.
Published: (2015-01-01) -
Within the Enemy’s Camp: Contribution of the granuloma to the dissemination, persistence and transmission of Mycobacterium tuberculosis
by: Christopher Ryan Shaler, et al.
Published: (2013-02-01) -
Editorial: Advances in Immunotherapeutic Approaches to Tuberculosis
by: Iris Estrada García, et al.
Published: (2021-04-01)